Skip to main content
. 2017 Jul 20;8(3):295–311. doi: 10.1007/s13167-017-0101-y

Table 5.

A summary of the epidemiologic assessments and causality conclusions for hepatitis A vaccine

Type vaccine Adverse event Epidemiologic assessment Studies contributing to epidemiologic assessment Causality conclusion
Hepatitis A vaccine Transverse myelitis Insufficient None Inadequate
MS Insufficient None Inadequate
Guillain–Barré syndrome Insufficient None Inadequate
Chronic inflammatory disseminated polyneuropathy Insufficient None Inadequate
Autoimmune hepatitis insufficient None Inadequate
HHS Vulnerability Disclosure